170 related articles for article (PubMed ID: 38517045)
1. Drug-target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk.
Sun X; Ping J; Guo X; Long J; Cai Q; Shu XO; Shu X
Mol Carcinog; 2024 May; 63(5):849-858. PubMed ID: 38517045
[TBL] [Abstract][Full Text] [Related]
2. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
[TBL] [Abstract][Full Text] [Related]
3. Mendelian randomization analyses identified bioavailable testosterone mediates the effect of sex hormone-binding globulin on prostate cancer.
Wan B; Lu L; Lv C
Andrology; 2023 Sep; 11(6):1023-1030. PubMed ID: 36524281
[TBL] [Abstract][Full Text] [Related]
4. Genetically proxied glucose-lowering drug target perturbation and risk of cancer: a Mendelian randomisation analysis.
Yarmolinsky J; Bouras E; Constantinescu A; Burrows K; Bull CJ; Vincent EE; Martin RM; Dimopoulou O; Lewis SJ; Moreno V; Vujkovic M; Chang KM; Voight BF; Tsao PS; Gunter MJ; Hampe J; Pellatt AJ; Pharoah PDP; Schoen RE; Gallinger S; Jenkins MA; Pai RK; ; ; Gill D; Tsilidis KK
Diabetologia; 2023 Aug; 66(8):1481-1500. PubMed ID: 37171501
[TBL] [Abstract][Full Text] [Related]
5. No evidence of genetic causal association between sex hormone-related traits and systemic lupus erythematosus: A two-sample Mendelian randomization study.
Yuan G; Yang M; Xie J; Xu K; Zhang F
Clin Rheumatol; 2023 Dec; 42(12):3237-3249. PubMed ID: 37495778
[TBL] [Abstract][Full Text] [Related]
6. Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.
Au Yeung SL; Schooling CM
BMJ Open Diabetes Res Care; 2019; 7(1):e000872. PubMed ID: 31908803
[TBL] [Abstract][Full Text] [Related]
7. Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.
Yarmolinsky J; Díez-Obrero V; Richardson TG; Pigeyre M; Sjaarda J; Paré G; Walker VM; Vincent EE; Tan VY; Obón-Santacana M; Albanes D; Hampe J; Gsur A; Hampel H; Pai RK; Jenkins M; Gallinger S; Casey G; Zheng W; Amos CI; ; ; ; Smith GD; Martin RM; Moreno V
PLoS Med; 2022 Feb; 19(2):e1003897. PubMed ID: 35113855
[TBL] [Abstract][Full Text] [Related]
8. Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis.
Hazelwood E; Sanderson E; Tan VY; Ruth KS; Frayling TM; Dimou N; Gunter MJ; Dossus L; Newton C; Ryan N; Pournaras DJ; O'Mara TA; Davey Smith G; Martin RM; Yarmolinsky J
BMC Med; 2022 Apr; 20(1):125. PubMed ID: 35436960
[TBL] [Abstract][Full Text] [Related]
9. Genetically proxied morning chronotype was associated with a reduced risk of prostate cancer.
Sun X; Ye D; Jiang M; Qian Y; Mao Y
Sleep; 2021 Oct; 44(10):. PubMed ID: 33878190
[TBL] [Abstract][Full Text] [Related]
10. Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
Sun L; Ding H; Jia Y; Shi M; Guo D; Yang P; Wang Y; Liu F; Zhang Y; Zhu Z
Breast Cancer Res; 2022 Feb; 24(1):12. PubMed ID: 35151363
[TBL] [Abstract][Full Text] [Related]
11. Association between genetically proxied HMGCR inhibition and male reproductive health: A Mendelian randomization study.
Yan Z; Xu Y; Li K; Liu L
Medicine (Baltimore); 2023 Sep; 102(39):e34690. PubMed ID: 37773823
[TBL] [Abstract][Full Text] [Related]
12. The effect of metformin on urate metabolism: Findings from observational and Mendelian randomization analyses.
Dai H; Hou T; Wang Q; Zhu Z; Zhu Y; Zhao Z; Li M; Xu Y; Lu J; Wang T; Ning G; Wang W; Bi Y; Zheng J; Xu M
Diabetes Obes Metab; 2024 Jan; 26(1):242-250. PubMed ID: 37807832
[TBL] [Abstract][Full Text] [Related]
13. Assessing the Casual Association between Sex Hormone Levels and Fracture Risk: A Two-Sample Mendelian Randomization Study.
Sun K; Ming Y; Xu J; Wu Y; Zeng Y; Wu L; Li M; Shen B
Orthop Surg; 2023 Dec; 15(12):3065-3074. PubMed ID: 37771125
[TBL] [Abstract][Full Text] [Related]
14. Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study.
Cai Y; Jun G; Zhuang X
Osteoporos Int; 2024 Jun; 35(6):1089-1098. PubMed ID: 38536446
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of metformin targets on cardiometabolic health in the general population and non-diabetic individuals: a Mendelian randomization study.
Zheng J; Xu M; Yang Q; Hu C; Walker V; Lu J; Wang J; Liu R; Xu Y; Wang T; Zhao Z; Yuan J; Burgess S; Au Yeung SL; Luo S; Anderson EL; Holmes MV; Smith GD; Ning G; Wang W; Gaunt TR; Bi Y
EBioMedicine; 2023 Oct; 96():104803. PubMed ID: 37734206
[TBL] [Abstract][Full Text] [Related]
16. New evidence for the effect of type 2 diabetes and glycemic traits on testosterone levels: a two-sample Mendelian randomization study.
Jiang C; Wang Y; Yang W; Yang X
Front Endocrinol (Lausanne); 2023; 14():1238090. PubMed ID: 37900148
[TBL] [Abstract][Full Text] [Related]
17. Putative causal inference for the relationship between obesity and sex hormones in males: a bidirectional Mendelian randomization study.
Wan B; Ma N; Zhou Z; Lv C
PeerJ; 2023; 11():e15760. PubMed ID: 37483981
[TBL] [Abstract][Full Text] [Related]
18. Lipid traits and type 2 diabetes risk in African ancestry individuals: A Mendelian Randomization study.
Soremekun O; Karhunen V; He Y; Rajasundaram S; Liu B; Gkatzionis A; Soremekun C; Udosen B; Musa H; Silva S; Kintu C; Mayanja R; Nakabuye M; Machipisa T; Mason A; Vujkovic M; Zuber V; Soliman M; Mugisha J; Nash O; Kaleebu P; Nyirenda M; Chikowore T; Nitsch D; Burgess S; Gill D; Fatumo S
EBioMedicine; 2022 Apr; 78():103953. PubMed ID: 35325778
[TBL] [Abstract][Full Text] [Related]
19. Circulating phosphorus concentration and risk of prostate cancer: a Mendelian randomization study.
Lv L; Ye D; Chen J; Qian Y; Fu AN; Song J; Yang H; Liu B; Sun X; Du L; Mao Y
Am J Clin Nutr; 2022 Feb; 115(2):534-543. PubMed ID: 34617559
[TBL] [Abstract][Full Text] [Related]
20. Unveiling potential drug targets for hyperparathyroidism through genetic insights via Mendelian randomization and colocalization analyses.
Chen B; Wang L; Pu S; Guo L; Chai N; Sun X; Tang X; Ren Y; He J; Hao N
Sci Rep; 2024 Mar; 14(1):6435. PubMed ID: 38499600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
